Universal CAR T Cell Therapy Helps Neat a Hard-to-Treat Pediatric Cancer
Acute lymphoblastic leukemia (ALL) accounts for 25% of all pediatric cancer cases in the United States. There are several options for treating ALL in children aged 1-10 years, but infants under one year of age generally have a much poorer prognosis. However, two infants diagnosed with ALL are cured after receiving initial experimental therapy using CAR […]